Beta Bionics Inc (NASDAQ:BBNX) price on Friday, May 23, fall -6.96% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.43.
A look at the stock’s price movement, the close in the last trading session was $15.51. Turning to its 52-week performance, $24.50 and $8.89 were the 52-week high and 52-week low respectively. Overall, BBNX moved 30.47% over the past month.
Beta Bionics Inc’s market cap currently stands at around $625.68 million, with investors looking forward to this quarter’s earnings report slated for in June.
Analysts have a consensus estimate of 19.52M for the company’s revenue for the quarter, with a low and high estimate of 19.03M and 20.4M respectively. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 84.6M, representing a 29.90% jump on that reported in the last financial year.
BBNX’s current price about 8.15% and 13.83% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 55.52, while 7-day volatility ratio is 4.94% and 6.73% in the 30-day chart. Further, Beta Bionics Inc (BBNX) has a beta value of 0, and an average true range (ATR) of 1.23.
If we refocus on Beta Bionics Inc (NASDAQ:BBNX), historical trading data shows that trading volumes averaged 519.60K over the past 3 months. The company’s latest data on shares outstanding shows there are 43.35 million shares.
The 23.38% of Beta Bionics Inc’s shares are in the hands of company insiders while institutional holders own 83.50% of the company’s shares. Current price change has pushed the stock -38.93% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the BBNX stock continues to rise going into the next quarter.
